To compare the AML-ETO simulation results with experimental data, we utilised a doxycycline-inducible expression system to generate 416b cells with inducible expression of AML1-ETO fused to a mCherry reporter via a self-cleaving 2A peptide spacer. The gene discussed is RUNX1; the disease is acute myeloid leukemia.